Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Thymic stromal lymphopoietin (TSLP) promotes hair growth, especially after skin injury.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Psychological interventions can improve mental health and quality of life in people with alopecia.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Chemical leukoderma is temporary, while chemical-induced vitiligo can be persistent and harder to treat.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Researchers made a mouse model with curly hair and hair loss by editing a gene.

Abnormal ECM and immune cell interactions can cause skin diseases.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Single-cell transcriptomics helps improve animal health and productivity by studying gene expression in individual cells.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.